Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote “FOR” All Proposed Items at the Upcoming Special Meeting of Stockholders

5M ago

GTBP

PremiumPress Releases

GT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia

5M ago

GTBP

More GTBP News >

GTBP News on the Web

2024-03-27

GT Biopharma Inc Down 3.44% To $4.33 After Earnings Beat

Investors Observer

Neutral

2024-03-27

GTBP Stock Earnings: GT Biopharma Beats EPS for Q4 2023

InvestorPlace

Neutral

2024-03-26

GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results

Yahoo Finance

Neutral

2024-02-01

GT Biopharma, Inc. Announces 1-for-30 Reverse Stock Split

Yahoo Finance

Neutral

2023-12-18

Should You Buy GT Biopharma Inc (GTBP) Stock on Monday?

Investors Observer

Neutral

2023-12-13

Buy Rating for GT Biopharma: High Efficacy and Expanded Potential in Oncology Therapeutics

TipRanks News

Neutral

2023-12-06

Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote “FOR” All Proposed Items at the Upcoming Special Meeting of Stockholders

Yahoo Finance

Bullish

2023-12-05

Where Does GT Biopharma Inc (GTBP) Stock Fall in the Biotechnology Field After It Has Gained 4.55% This Week?

Investors Observer

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GTBP’s Media Buzz Sentiment?

Currently, no data Available

What is GTBP’s weekly average amount of articles?

Currently, no data Available

What is GTBP’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

NBIXNeurocrine

AMEDAmedisys

HSTMHealthStream

IMVTImmunovant

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing